Management of African trypanosomiasis of the CNS: Polysomnography as a noninvasive staging tool

Future Neurology

Volumn 7, Issue 4, 2012, Pages 453-472

  Buguet, Alain ^a,b   Chapotot, Florian ^c   Ngampo, Stéphane ^d   Bouteille, Bernard ^e   Cespuglio, Raymond ^b  

^a Siafoumou ^*  (Congo)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF CHICAGO   (United States)

^d Programme National de Lutte Contre la Trypanosomiase Humaine Africaine   (Congo)

^e DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

B lymphocytes; cerebrospinal fluid; diagnosis; human African trypanosomiasis; polysomnography; post treatment follow up; sleeping sickness; staging; Trypanosoma brucei gambiense; white blood cell counts

Indexed keywords

EFLORNITHINE; MELARSOPROL; NIFURTIMOX; PENTAMIDINE;

AFRICAN TRYPANOSOMIASIS; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID EXAMINATION; CIRCADIAN RHYTHM SLEEP DISORDER; CONGO; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAM; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LUMBAR PUNCTURE; NONHUMAN; NONREM SLEEP; OUTCOME ASSESSMENT; PATIENT MONITORING; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPATHY; REFERENCE VALUE; RELAPSE; REM SLEEP; REVIEW; SLEEP DISORDER; SLEEP PATTERN; SYMPTOM; TREATMENT RESPONSE; TRYPANOSOMA BRUCEI; TRYPANOSOMA GAMBIENSE; TRYPANOSOMA RHODESIENSE; TSETSE FLY; WAKEFULNESS;

EID: 84863730516     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.12.41     Document Type: Review

References (60)

1. Martin G, Leboeuf P, Roubaud E. Rapport de La Mission D'études De La Maladie Du Sommeil Au Congo Français 1906-1908. Masson et Cie Editeurs, Paris, France (1909). The report that compiled several articles, which described and specified in detail the clinical syndromes of human African trypanosomiasis (HAT).
2. Blum J, Schmid C, Burri C. Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop. 97(1), 55-64 (2006).
3. Braakman HM, van de Molengraft FJ, Hubert WW, Boerman DH. Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology 66(7), 1094-1096 (2006).
4. Kennedy PG. Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int. J. Parasitol. 36(5), 505-512 (2006).
5. Magnus E, Vervoort T, Van Meirvenne N. A card agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomes. Ann. Soc. Belge Méd. Trop. 58(3), 169-176 (1978).
6. Woo PT. Evaluation of the haematocrit centrifuge and other techniques for the field diagnosis of human trypanosomiasis and filariasis. Acta Trop. 28(3), 298-303 (1971).
7. Lumsden WH, Kimber CD, Evans DA, Doig SJ. Trypanosoma brucei: miniature anion-exchange centrifugation technique for detection of low parasitaemias: adaptation for field use. Trans. R. Soc. Trop. Med. Hyg. 73(3), 312-317 (1979).
8. Lejon V, Roger I, Mumba Ngoyi D et al. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis. Clin. Infect. Dis. 47(1), 15-22 (2008).
9. Miézan TW, Meda AH, Doua F, Djé NN, Lejon V, Büscher P. Single centrifugation of cerebrospinal fluid in a sealed Pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans. R. Soc. Trop. Med. Hyg. 94(3), 293 (2000).
10. Büscher P, Mumba Ngoyi D, Kaboré J et al. Improved models of mincentrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl. Trop. Dis. 3(11), E471 (2009).
11. Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P. Options for field diagnosis of human African trypanosomiasis. Clin. Microbiol. Rev. 18(1), 133-146 (2005).
12. Bouteille B, Mpandzou G, Cespuglio R et al. Cerebrospinal fluid B lymphocyte identification for diagnosis and follow-up in human African trypanosomiasis. Trop. Med. Int. Health 15(4), 454-461 (2010). Describes the improvement of invasive cerebrospinal fluid examination by looking at the qualitative aspect of cells present in the cerebrospinal fluid.
13. Mpanya A, Hendrickx D, Vuna M et al. Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo. PLoS Negl. Trop. Dis. 6(1), E1467 (2012).
14. Priotto G, Kasparian S, Mutombo W et al. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, Phase III, non-inferiority trial. Lancet 374(9683), 56-64 (2009).
15. Buguet A, Cespuglio R, Louis F, Bouteille B. Diagnostic de la Trypanosomose Humaine Africaine (Maladie du Sommeil). Editions Universitaires Européennes, Sarrebruck, Germany (2011).
16. Mackenzie S. Negro lethargy. Lancet 136(3508), 1100-1101 (1890). First clinical description of nychthemeral disturbances of the sleep - wake alternation in HAT patients.
17. Manson-Bahr P. Manson's tropical diseases. A Manual Of Diseases Of Warm Climates. Cassel London, UK (1942).
18. Lhermitte J. La Maladie Du Sommeil Et Les Narcolepsies. Etablissements d'imprimerie L. Severeyns, Bruxelles, Belgium (1910). First detailed description of narcoleptic-like attacks in HAT.
19. Bert J, Collomb H, Fressy J, Gastaud H. Etude électroencé phalographique du sommeil nocturne au cours de la trypanosomiase humaine africaine. In: Le Sommeil de Nuit Normal et Pathologique, Études électroencéphalographiques. Fischgold H (Ed.). Paris, France 334-352 (1965). The first polysomnographic study in HAT.
20. Schwartz BA, Escande C. Sleeping sickness: sleep study of a case. Electroencephalogr. Clin. Neurophysiol. 29(1), 83-87 (1970).
21. Sanner BM, Büchner N, Kotterba S, Zidek W. Polysomnography in acute African trypanosomiasis. J. Neurol. 247(11), 878-879 (2000).
22. Buguet A, Gati R, Sèvre JP et al. 24-hour polysomnographic evaluation in a patient with sleeping sickness. Electroencephalogr. Clin. Neurophysiol. 72(6), 471-478 (1989). The first polysomnographic analysis over a period of 24 h, which allowed the description of sleep-onset rapid eye movement periods (SOREMPs) and circadian alterations of the sleep-wake alternation.
23. Buguet A, Rivolier J, Jouvet M. Human sleep in Antarctica. Sleep 10(4), 374-382 (1987).
24. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. NIH publications no204, Public Health Service, U.S. Govt. P.O., Washington, DC, USA (1968).
25. Billiard M, Ondzé B. Troubles de l'éveil. Deuxième partie: troubles secondaires de l'éveil. Rev. Neurol. 157(5), 480-496 (2001).
26. Billiard M, Carlander B. Other hypersomnias. In: Sleep, Physiology, Investigations and Medicine. Billiard M (Ed.). Kluwer Academic/Plenum Publishers, NY, USA, 447-456 (2003).
27. Bédat-Millet AL, Charpentier S, Monge-Strauss MF, Woimant F. Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging. Rev. Neurol. 156(5), 505-509 (2000).
28. Buguet A, Bourdon L, Bouteille B et al. The duality of sleeping sickness: focusing on sleep. Sleep Med. Rev. 5(2), 139-153 (2001). The description of the polysomnographic syndrome of stage 2 HAT.
29. Buguet A, Tapie P, Bert J. Reversal of the sleep-wake cycle disorder of sleeping sickness after trypanosomicide treatment. J. Sleep Res. 8(3), 225-235 (1999).
30. Montmayeur A, Brosset C, Imbert P, Buguet A. Cycle veille-sommeil au décours d'une trypanosomose humaine africaine à Trypanosoma brucei rhodesiense chez deux parachutistes français. Bull. Soc. Pathol. Ex. 87(5), 368-371 (1994).
31. Buguet A, Bisser S, Josenando T, Chapotot F, Cespuglio R. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness. Acta Trop. 93(1), 107-117 (2005). The hypothesis that polysomnography may be used as a noninvasive staging tool in HAT.
32. Darsaud A, Bourdon L, Mercier S et al. Twenty-four hour disruption of the sleep-wake cycle and sleep-onset REM-like episodes in a rat model of African trypanosomiasis. Sleep 27(1), 42-46 (2004).
33. Doua F, Miézan TW, Sanon Singaro JR, Boa FY, Baltz T. The efficacy of pentamidine in the treatment of early-stage Trypanosoma brucei gambiense trypanosomiasis. Am. J. Trop. Med. Hyg. 55(6), 586-588 (1996).
34. World Health Organization Recommendations of the informal consultation on issues for clinical product development for human African trypanosomiasis. WHO/CDS/NTD/IDM/2007.1., Geneva, Switzerland (2007).
35. Iber C, Ancoli-Israel S, Chesson A, Quan SF. For the American Academy of Sleep Medicine. The AASM Manual For The Scoring Of Sleep And Associated Events: Rules, Terminology And Technical Specifications (1st Edition). American Academy of Sleep Medicine, IL, USA (2007).
36. Balasegaram M, Young H, Chappuis F et al. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans. R. Soc. Trop. Med. Hyg. 103(3), 280-290 (2009).
37. Buguet A, Bouteille B, Mpandzou G et al. La recherche sur la maladie du sommeil (trypanosomose humaine africaine) en République du Congo de 2004 à 2009. Editions Les Manguiers, Brazzaville, Congo (2009).
38. Mpandzou G, Ngampo S, Bandzouzi B et al. Polysomnographic diagnosis of meningoencephalitic gambiense African trypanosomiasis in an infant. Sci. Med. Afr. 1(2), 105-109 (2009).
39. Mpandzou G, Cespuglio R, Ngampo S et al. Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant. J. Neurol. Sci. 305(1-2), 112-115 (2011).
40. Rechtschaffen A, Wolpert EA, Dement WC. Nocturnal sleep of narcoleptics. Electroencephalogr. Clin. Neurophysiol. 13, 599-609 (1963).
41. Richardson GS, Carskadon MA, Flagg W, van den Hoed J, Dement WC, Mitler MM. Excessive daytime sleepiness in man: multiple sleep latency test in narcoleptic and control subjects. Electroencephalogr. Clin. Neurophysiol. 45(5), 621-627 (1978).
42. Mignot E, Lin L, Finn L et al. Correlates of sleep-onset REM periods during the multiple sleep latency test in community adults. Brain 129(Pt 6), 1609-1623 (2006). i anion exchange
43. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 369(9560), 499-511 (2007).
44. Dauvilliers Y, Bisser S, Chapotot F et al. Hypocretin and human African trypanosomiasis. Sleep 31(3), 348-354 (2008).
45. Kupfer DJ, Foster FG. Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 300(7779), 684-686 (1972).
46. Morehouse RL, Flanigan M, MacDonald DD, Braha D, Shapiro C. Depression and short REM latency in subjects with chronic fatigue syndrome. Psychosom. Med. 60(3), 347-351 (1998).
47. Landolt HP, Gillin JC. Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management. CNS Drugs 15(5), 413-425 (2001).
48. Vgontzas AN, Bixler EO, Kales A, Centurione A. Daytime sleepiness and REM sleep abnormalities in Prader-Willi syndrome: evidence of generalized hypoarousal. Int. J. Neurosci. 87(3-4), 127-139 (1996).
49. Billiard M. Sleep: Physiology, Investigations and Medicine. Kluwer Academic/Plenum Publishers, NY, USA (2003).
50. Akerstedt T. Sleepiness as a consequence of shift work. Sleep 11(1), 17-34 (1988).
51. Daurat A, Benoit O, Buguet A. Effects of zopiclone on the rest/activity rhythm after a westward flight across five time zones. Psychopharmacology 149(3), 241-245 (2000).
52. Buguet AGC, Roussel BHE, Watson WJ, Radomski MW. Cold-induced diminution of paradoxical sleep in man. Electroencephalogr. Clin. Neurophysiol. 46(1), 29-32 (1979).
53. Buguet A, Py P, Romanet JP. Sleep after hourly forced awakenings in young and older adults. In: Facts and Research in Gerontology, Supplement. Vellas P, Albarede JL, Garry PJ (Eds). Paris, France, 137-147 (1995).
54. Takeuchi T, Fukuda K, Murphy TI. Elicitation of sleep-onset REM periods in normal individuals using the sleep interruption technique (SIT). Sleep Med. 3(6), 479-488 (2002).
55. Miyasita A, Fukuda K, Inugami M. Effects of sleep interruption on REM-NREM cycle in nocturnal human sleep. Electroencephalogr. Clin. Neurophysiol. 73(2), 107-116 (1989).
56. Singh M, Drake CL, Roth T. The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep 29(7), 890-895 (2006).
57. Becq G, Charbonnier S, Chapotot F et al. Comparison between five classifiers for automatic scoring of human sleep recordings. In: Softcomputing in Knowledge Discovery, Methods and Applications. Halgamuge S, Wang L (Ed.). Springer Verlag, Berlin, Germany, 113-127 (2005).
58. Charbonnier S, Zoubek L, Lesecq S, Chapotot F. Self-evaluated automatic classifier as a decision support tool for sleep/wake staging. Comput. Biol. Med. 41(6), 380-389 (2011).
59. Buguet A, Montmayeur A, Bourdon L et al. La maladie du sommeil: trouble majeur des rythmes circadiens. Rev. Sci. Tech. Défense 29(1), 107-117 (1995).
60. Njamnshi AK, Seke Etet PF, Perrig S et al. Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot study. PLoS Negl. Trop. Dis. 6(2), E1525 (2012).